{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:15:11Z","timestamp":1785420911890,"version":"3.56.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jtha.2025.07.031","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T15:52:00Z","timestamp":1754668320000},"page":"234-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Anti-Xa directed low-molecular-weight heparin dosing to reduce the risk of venous thromboembolism in pregnant women with inherited antithrombin deficiency"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6264-128X","authenticated-orcid":false,"given":"Caroline","family":"Dix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Breen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aine","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley J.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.07.031_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-0038-1625983","article-title":"Risk of venous thrombosis in antithrombin deficiency: a systematic review and Bayesian meta-analysis","volume":"44","author":"Croles","year":"2018","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2025.07.031_bib2","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1182\/blood-2008-10-184879","article-title":"Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives","volume":"113","author":"Lijfering","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.07.031_bib3","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1182\/blood.V94.8.2590.420k40_2590_2594","article-title":"Gene-gene and gene-environment interactions determine risk of thrombosis in families with inherited antithrombin deficiency","volume":"94","author":"van Boven","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.07.031_bib4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.thromres.2004.08.004","article-title":"Haemostatic changes in pregnancy","volume":"114","author":"Brenner","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.07.031_bib5","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ajog.2005.11.008","article-title":"Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality","volume":"194","author":"James","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jtha.2025.07.031_bib6","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1182\/bloodadvances.2018024802","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy","volume":"2","author":"Bates","year":"2018","journal-title":"Blood Adv"},{"issue":"Suppl","key":"10.1016\/j.jtha.2025.07.031_bib7","doi-asserted-by":"crossref","first-page":"e691S","DOI":"10.1378\/chest.11-2300","article-title":"VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2025.07.031_bib9","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/AOG.0000000000002706","article-title":"ACOG Practice Bulletin No. 196: thromboembolism in pregnancy","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jtha.2025.07.031_bib12","doi-asserted-by":"crossref","first-page":"762","DOI":"10.15585\/mmwr.mm6835a3","article-title":"Racial\/ethnic disparities in pregnancy-related deaths \u2014 United States, 2007\u20132016","volume":"68","author":"Petersen","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jtha.2025.07.031_bib13","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1600-0412.2011.01098.x","article-title":"Efficacy of obstetric thromboprophylaxis and long-term risk of recurrence of venous thromboembolism","volume":"90","author":"Lindqvist","year":"2011","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jtha.2025.07.031_bib14","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0002-9378(99)70091-8","article-title":"Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy","volume":"181","author":"Casele","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jtha.2025.07.031_bib15","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1592\/phco.31.7.678","article-title":"Dosing and monitoring of low-molecular-weight heparin in high-risk pregnancy: single-center experience","volume":"31","author":"Shapiro","year":"2011","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jtha.2025.07.031_bib16","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1016\/S2352-3026(20)30007-7","article-title":"Risk of pregnancy-related venous thromboembolism and obstetrical complications in women with inherited type I antithrombin deficiency: a retrospective, single-centre, cohort study","volume":"7","author":"Abbattista","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtha.2025.07.031_bib17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.thromres.2018.11.006","article-title":"The influence of specific mutations in the AT gene (SERPINC1) on the type of pregnancy related complications","volume":"173","author":"Kovac","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.07.031_bib18","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/01.ATV.16.6.742","article-title":"Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency. A cooperative, retrospective study. Gesellschaft fur Thrombose- und Hamostaseforschung (GTH) Study Group on Natural Inhibitors","volume":"16","author":"Pabinger","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2025.07.031_bib19","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1161\/01.ATV.19.4.1026","article-title":"Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: a multicenter collaborative family study","volume":"19","author":"Bucciarelli","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2025.07.031_bib20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1055\/s-0038-1645218","article-title":"Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women","volume":"63","author":"Conard","year":"1990","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.07.031_bib21","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1055\/s-0038-1657712","article-title":"Risk factors for pregnancy associated venous thromboembolism","volume":"78","author":"McColl","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.07.031_bib22","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1160\/TH13-01-0077","article-title":"How I treat heterozygous hereditary antithrombin deficiency in pregnancy","volume":"110","author":"Bramham","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.07.031_bib24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/bjh.18239","article-title":"Thrombophilia testing: a British Society for Haematology guideline","volume":"198","author":"Arachchillage","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.07.031_bib25","article-title":"Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (fifth edition)","author":"Kopp","year":"2025","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.jtha.2025.07.031_bib26","first-page":"e106","article-title":"Prevention and management of postpartum haemorrhage","volume":"124","author":"Mavrides","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.jtha.2025.07.031_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jth.14648","article-title":"Recommendations for clinical laboratory testing for antithrombin deficiency; communication from the SSC of the ISTH","volume":"18","author":"Van Cott","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.07.031_bib28","article-title":"Active versus expectant management for women in the third stage of labour","volume":"3","author":"Begley","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtha.2025.07.031_bib29","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/00001721-200312000-00007","article-title":"Thromboprophylaxis with unmonitored intermediate-dose low molecular weight heparin in pregnancies with a previous arterial or venous thrombotic event","volume":"14","author":"Hunt","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2025.07.031_bib30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/jp.2009.164","article-title":"Fluctuations in anti-factor Xa levels with therapeutic enoxaparin anticoagulation in pregnancy","volume":"30","author":"Friedrich","year":"2010","journal-title":"J Perinatol"},{"key":"10.1016\/j.jtha.2025.07.031_bib31","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.thromres.2014.09.033","article-title":"A case series of LMWH use in pregnancy: should trough anti-Xa levels guide dosing?","volume":"134","author":"Berresheim","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.07.031_bib32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/1753495X17741025","article-title":"Severe antithrombin deficiency in pregnancy: achieving adequate anticoagulation","volume":"12","author":"Pearson-Stuttard","year":"2019","journal-title":"Obstet Med"},{"key":"10.1016\/j.jtha.2025.07.031_bib33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00277-013-1892-0","article-title":"Prevention, management and extent of adverse pregnancy outcomes in women with hereditary antithrombin deficiency","volume":"93","author":"Rogenhofer","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtha.2025.07.031_bib34","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.thromres.2014.07.025","article-title":"Characterisation of antithrombin levels in pregnancy","volume":"134","author":"James","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.07.031_bib35","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1182\/blood.2019002927","article-title":"How I treat patients with hereditary antithrombin deficiency","volume":"134","author":"Pabinger","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.07.031_bib36","first-page":"343","article-title":"Recombinant human antithrombin in pregnant patients with hereditary antithrombin deficiency: integrated analysis of clinical data","volume":"33","author":"Paidas","year":"2016","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.jtha.2025.07.031_bib37","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/MBC.0000000000000835","article-title":"Antithrombin concentrate during pregnancy in congenital antithrombin deficiency: a single-center experience","volume":"30","author":"Bruzzese","year":"2019","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2025.07.031_bib38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.thromres.2017.05.017","article-title":"Management of hereditary antithrombin deficiency in pregnancy","volume":"157","author":"James","year":"2017","journal-title":"Thromb Res"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625004945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625004945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T08:41:14Z","timestamp":1767602474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625004945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1538783625004945"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.07.031","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-Xa directed low-molecular-weight heparin dosing to reduce the risk of venous thromboembolism in pregnant women with inherited antithrombin deficiency","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.07.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}